Dr. Ashley Victoria Mack, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 8523 Old State Rd, Holly Hill, SC 29059 Phone: 803-496-3954 |
Rachel Osteen Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 904 Holly St, Holly Hill, SC 29059 Phone: 803-496-0007 |
Lindsey Brletich, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 8523 Old State Rd, Holly Hill, SC 29059 Phone: 803-496-3954 |
Troy Blakely Lamb Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 8530 Old State Rd., Holly Hill, SC 29059 Phone: 803-496-3954 |
Michael James Myers, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 8523 Old State Road, Holly Hill, SC 29059 Phone: 803-496-3954 Fax: 803-496-2554 |
Melanie Rodgers Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 8523 Old State Rd, Holly Hill, SC 29059 Phone: 803-496-3954 |
News Archive
Head and neck cancer is one of the leading causes of cancer-related deaths worldwide, and squamous cell carcinomas (HNSCC) account for the majority of these cases.
Boston University researchers have developed a simple diagnostic tool that can quickly identify dangerous viruses like Ebola and Marburg. The biosensor, which is the size of a quarter and can detect viruses in a blood sample, could be used in developing nations, airports and other places where natural or man-made outbreaks could erupt.
UC Davis Health System dermatologists, using videoconferencing technology known as teledemedicine, have determined that live interactive consultations can improve clinical outcomes for patients because they usually involve beneficial changes in medical diagnosis and disease management that otherwise might not occur.
A first-of-its-kind randomized clinical trial offers strong and perhaps surprising evidence that a combination of two targeted melanoma drugs when given continuously keeps patients' cancer from growing or spreading longer when compared with intermittent treatment, according to study results to be presented at the 2020 virtual annual meeting of the American Association for Cancer Research.
Transgenomic, Inc., a global biotechnology company advancing personalized medicine in cardiology, oncology, and inherited diseases through diagnostic tests as well as clinical and research services, today announced an agreement with Raptor Pharmaceuticals Inc. to provide genetic testing services for Raptor's clinical trial (RP103-MITO-001) evaluating RP103 as a potential treatment for Leigh syndrome and other inherited mitochondrial disorders.
› Verified 9 days ago